Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical atorvastatin added to tacrolimus for non-segmental vitiligo
IRCT20200714048099N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Nov 2020
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Vitiligo comparing Atorvastatin plus tacrolimus with Placebo plus tacrolimus (2 arms). Primary endpoint: VASI change. Started Nov 2020; status: completed.
02
Drugs
atorvastatintacrolimus
03
Conditions
Vitiligo
Beyond the preview
Go deeper on IRCT20200714048099N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200714048099N1.